Research study Program year 2025 Source: CMS Open Payments

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of siRNA Gene Silencing for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Participants With Genetic Risk Factors

ClinicalTrials.gov NCT05519475

Research payments

$4,221,806

1,107 payments

Through program year 2025, $4,221,806 in research payments was reported against A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of siRNA Gene Silencing for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Participants With Genetic Risk Factors, across 1,107 payments, paid by Regeneron Pharmaceuticals, Inc..

Paid by: Regeneron Pharmaceuticals, Inc.
ClinicalTrials.gov: NCT05519475

By program year

1 row

Year	Kind	Amount	Payments
2025	Research	$4,221,806	1,107

Breakdown

Who paid Research payments · program year 2025

Regeneron Pharmaceuticals, Inc. $4,221,806 1,107 payments

Who received the money Research payments · program year 2025

Pinnacle Clinical Research LLC Organisation paid for research $548,995 137 payments
Geisinger Clinic Organisation paid for research $437,583 55 payments
Adobe Clinical Research LLC Organisation paid for research $401,384 57 payments
The Institute For Liver Health II LLC Organisation paid for research $250,605 79 payments
Evolution Clinical Trials Organisation paid for research $176,774 44 payments
Ark Clinical Research LLC Organisation paid for research $169,621 25 payments
Tandem Clinical Research Gi LLC Organisation paid for research $147,727 62 payments
South Texas Research Institute Organisation paid for research $146,845 29 payments
Pioneer Research Solutions INC Organisation paid for research $143,704 57 payments
Texas Digestive Disease Consultants Pllc Organisation paid for research $141,291 29 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.